Stocks
Ionis Pharmaceuticals (IONS) EBITDA margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 32.6% | -23.6% | -2.59% | -95.6% | -41.0% | -42.2% | ||
| Changes by years, y/y, % | +43pp | -56pp | +21pp | -93pp | +55pp | +31.9% | |||
Ionis Pharmaceuticals. EBITDA margin, %
Ionis Pharmaceuticals. EBITDA margin, changes, pp
Ionis Pharmaceuticals (IONS) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA margin, % | ? | -74.0% | -31.4% | -85.4% | -0.51% | -120.4% | -42.2% | |
| Changes by years, y/y, % | -36pp | +39pp | -54pp | +235pp | -46pp | |||
| Changes by quarters, q/q, % | +161pp | +43pp | -54pp | +85pp | -120pp | |||
